mPharma: Africa pharmacy tech 2026

mPharma (Ghana, founded 2013) digitizes Africa pharmacy supply chain. Mutti pharmacy network (700+ franchised pharmacies), drug inventory management, supply chain financing. $100M+ raised (TPG, JAM Fund, Helios).

TL;DR

- mPharma: Africa pharmacy tech leader, founded 2013.

- Mutti: 700+ pharmacy franchise network.

- $100M+ raised (TPG, JAM Fund, Helios).

- Presence Ghana, Nigeria, Kenya, Rwanda, Ethiopia, Zambia.

Model

Mutti pharmacy network

• Independent pharmacies join franchise
• Free inventory management software
• Bulk purchasing power (manufacturer discounts)
• Shared Mutti branding
• Shared customer loyalty program

Vendor-Managed Inventory (VMI)

• mPharma manages pharmacy stock
• No-stockout thanks to data forecasting
• Pharmacy only pays sold

Drug supply chain

• Direct manufacturer partnerships (Pfizer, Novartis, Sanofi)
• Eliminates multiple intermediaries
• End-customer prices reduced 30-50%

Mutti Doctor

• Telemedicine prescriptions
• Associated doctors network
• Online consultations

QualityRx

• Drug quality assurance
• Counterfeit detection
• Supply chain traceability

2026 metrics

• 700+ pharmacies Mutti network
• 8 country presence
• $100M+ raised cumulative
• 5M+ patients served annually
• Revenue: ~$50M ARR estimated

Africa use cases

Patients

• Reduced drug prices (30-50% off)
• Guaranteed stock availability
• Mutti loyalty rewards
• Integrated telemedicine

Independent pharmacies

• Inventory financing
• No capital tied-up
• Shared branding
• Customer analytics

Manufacturers

• Direct access network pharmacies
• Improved demand forecasting
• Grey market reduction

Government health

• Anti-counterfeit tracking
• Drug availability mapping
• Public health insights

Tech stack

• Cloud: AWS Cape Town
• Mobile: Android offline pharmacy app
• Backend: Node.js microservices
• Data: Snowflake warehouse
• Standards: GS1 barcodes, partial FHIR

Funding

• $100M+ raised
• TPG Growth, JAM Fund (Daniel Ek Spotify)
• Helios Investment Partners
• CDC, Proparco DFIs
• Series D 2023: $50M+

2026 competitors

• DrugStoc (Nigeria): alternative pharmacy supply chain
• Lifestores (Nigeria): healthcare delivery + EMR
• Reliance HMO (Nigeria): insurance integration
• MyPharma: direct pharmacy chains

Challenges

• Regulation: country-specific pharmacy laws
• Counterfeit drugs: prevalent West Africa
• Cold chain: vaccines, biologics
• Forex: USD-pricing manufacturers
• Public sector: slow integrations

Tech opportunities

• Cold chain IoT: sensors monitor vaccine temp
• Counterfeit detection: blockchain, ML
• Pharmacy POS: accounting integrations
• AI drug interaction: LLM-based
• Healthcare insurance + pharmacy bundle

FAQ

Q: Africa pharmacy tech builders?

A: Cold chain IoT, ML counterfeit, vertical pharmacy POS, Pharma insurance integrations, veterinary/agritech drugs niches.

Q: Invest mPharma?

A: Private, equity rounds. Potential Africa IPO 2026-2028.

Q: Model replicable other sectors?

A: VMI + franchise + supply chain financing pattern transferable agritech inputs, FMCG retail, B2B distribution (cf T9).

Conclusion

2026 mPharma: Africa pharmacy tech leader, $100M+ raised, 700+ Mutti pharmacies. Innovative VMI + franchise + supply chain financing model. For Africa healthtech builders, mPharma case study pattern vertical integration pharmacy + supply chain + telemedicine. Healthcare + fintech + supply chain convergence = new 50B$+ Africa pharmaceuticals market by 2030.